- Home
- AMLX vs STBA Comparison
AMLX vs STBA Comparison
Compare AMLX & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | STBA |
|---|---|---|
| Founded | 2014 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AMLX | STBA |
|---|---|---|
| Price | $17.61 | $44.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 6 |
| Target Price | $20.11 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 1.2M | 179.2K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | ★ 65.46 | 2.35 |
| EPS | N/A | ★ 3.49 |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | $10.20 |
| Revenue Next Year | N/A | $4.14 |
| P/E Ratio | ★ N/A | $12.65 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $4.41 | $34.01 |
| 52 Week High | $18.61 | $44.91 |
Technical Indicators
Market Signals| Indicator | AMLX | STBA |
|---|---|---|
| Relative Strength Index (RSI) | 64.35 | 66.14 |
| Support Level | $13.19 | $42.08 |
| Resistance Level | N/A | $44.58 |
| Average True Range (ATR) | 0.91 | 0.84 |
| MACD | 0.26 | 0.16 |
| Stochastic Oscillator | 83.26 | 87.69 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.